Granulex (Mylan Institutional Inc.)


Welcome to the PulseAid listing for the Granulex drug offered from Mylan Institutional Inc.. This Standardized Chemical Allergen [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Allergens [Chemical/Ingredient] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Mylan Institutional Inc.
NON-PROPRIETARY NAME: trypsin, balsam peru and castor oil
SUBSTANCE NAME: CASTOR OIL; BALSAM PERU; TRYPSIN, UNSPECIFIED FORM
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Standardized Chemical Allergen [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Allergens [Chemical/Ingredient]
ROUTE: TOPICAL
DOSAGE FORM: SPRAY
MARKETING CATEGORY NAME: UNAPPROVED DRUG OTHER
START MARKETING DATE: 1967-03-01
END MARKETING DATE: 2018-05-31


Granulex HUMAN PRESCRIPTION DRUG Details:

Item DescriptionGranulex from Mylan Institutional Inc.
LABELER NAME: Mylan Institutional Inc.
DEA SCHEDULE:
ACTIVE STRENGTH: 788; 87; .12(mg/g; mg/g; mg/g)
START MARKETING DATE: 1967-03-01
END MARKETING DATE: 2018-05-31
PRODUCT ID: 51079-621_229e6420-ed55-46c6-a696-471e008d4562
PRODUCT NDC: 51079-621
APPLICATION NUMBER:

Other CASTOR OIL; BALSAM PERU; TRYPSIN, UNSPECIFIED FORM Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Mylan Institutional Inc.Granulex